Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease.
Simone SaccoAkash VirupakshaiahNico PapinuttoVinícius Andreoli SchoepsAmit AkulaHaojun ZhaoJennifer AronaWilliam A SternJanet ChongJanace HartScott S ZamvilPascal SatiRoland G HenryEmmanuelle WaubantPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
The %CVS+ and PRLs are highly specific markers of POMS. After proper validation on larger multicenter cohorts, consideration should be given to including such imaging markers for diagnosing POMS at disease onset.